ITRM ITERUM THERAPEUTICS PLC Delisting Actions 8-K Filing 2024 - Nasdaq Compliance Iterum Therapeutics plc has been notified by Nasdaq that it does not meet the minimum stockholders equity requirement for continued listing, but has been granted an extension until September 30, 2024, to comply, with a hearing scheduled for November 21, 2024, to present a compliance plan.Get access to all SEC 8-K filings of the ITERUM THERAPEUTICS PLC